NEW YORK (360Dx) — Evogen announced today that it has received a $224,515 grant from the National Institutes of Health to continue development of a protein biomarker-based diagnostic for epilepsy.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss strategies for urinary tract infection (UTI) testing with the focus of detecting avoidable urine cultures.